Business
Vertex Pharmaceuticals Announces the Date of its Second Quarter 2006 Financial Results Conference Call and Webcast
Vertex Pharmaceuticals Announces the Date of its Second Quarter 2006 Financial Results Conference Call and Webcast.
About this update from Vortex Energy Corp.
[{"type":"text","content":"\n\n\n\n\nCAMBRIDGE, Mass., July 6 /CNW/ -- Vertex Pharmaceuticals\nIncorporated (Nasdaq: VRTX) will announce its second quarter 2006 financial\nresults on Wednesday, July 26, 2006 after the financial markets close. The\nCompany will host a conference call at 5:00 p.m. EDT. The conference call\nalso will be webcast.\nThe live webcast will be available to all interested parties through\nVertex's website, http://www.vrtx.com, and will be archived on the Company's\nwebsite until August 9, 2006. To access the webcast, go to the investor\nsection and select 'Events & Presentations.' To ensure a timely connection,\nit is recommended that users register at least 15 minutes prior to the\nscheduled webcast.\n\nAbout Vertex\nVertex Pharmaceuticals Incorporated is a global biotechnology company\ncommitted to the discovery and development of breakthrough small molecule\ndrugs for serious diseases. The Company's strategy is to commercialize its\nproducts both independently and in collaboration with major pharmaceutical\ncompanies. Vertex's product pipeline is principally focused on viral\ndiseases, inflammation, autoimmune diseases and cancer. Vertex co-promotes\nthe HIV protease inhibitor, Lexiva, with GlaxoSmithKline.\nLexiva is a registered trademark of the GlaxoSmithKline group of\ncompanies.\nVertex's press releases are available at http://www.vrtx.com.\n\n\n\n","length":1431,"tagName":"div"}]